Like & Follow Us
(954) 760-7836
PROPEL - Sinusitis Advanced Treatment

Introducing PROPEL

PROPEL is a medical breakthrough that is proven to improve the results of sinus surgery. It is the first and only device clinically shown to keep the sinuses open after surgery, precisely deliver anti-inflammatory medication, and then dissolve.

The innovative sinus stent decreases post-operative scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids and their potential side effects.

The PROPEL sinus stent is placed in the sinus after surgery to promote healing and reduce the need for additional post-operative procedures.

You can do more research here

Call 954-760-7836 today to book an appointment or to get your questions answered!

Don't Just Treat the Symptoms. Treat the Source.

Sinus surgery with PROPEL is clinically proven to provide relief by targeting inflammation, the primary characteristic of chronic sinusitis.2

01 | OPENS

After sinus surgery, PROPEL is placed to help prop open the sinus.


PROPEL delivers medicine directly to the sinus to reduce inflammation that could block the opening.


As the sinus heals open, PROPEL is designed to dissolve within 45 days.

Next Steps

Make an appointment to discuss the PROPEL treatment today.


1. Han JK, Marple BF, Smith TL et al. Int Forum Allergy Rhinol. 2012 2:271-279.

2. Forwith KD, Chandra RK, Yun PT, et al. ADVANCE: A multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope. 2011; 121:2473-2480.

The PROPEL sinus implants are intended for use following sinus surgery to maintain the sinus openings and to locally deliver a drug to the sinuses: PROPEL for use in the ethmoid sinus, PROPEL Mini for use in the ethmoid sinus and frontal sinus opening and PROPEL Contour for use in the frontal and maxillary sinus openings. The products are intended for use in patients ≥18 years of age. These products are not intended for people who are, allergic to the drug (mometasone furoate) or to certain polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, movement of the implant (within or out of the sinus), possible side effects of the drug, infection, and nose bleed. For more information on the risks and benefits of PROPEL sinus implants, please talk to your doctor. The FDA approved labeling can be found at Rx only.

INTERSECT ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries. is a trademark of Intersect ENT, Inc.